StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.86+0.16 (+5.98%)

Close on Nov 17, 2026Market cap $115.47MP/E –Yield –

Molecular Partners price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Molecular Partners's price to sales ratio was 31.4× on Feb 27, 2026, against 26.0× a year earlier. Over the last 5 years it ranged from 0.6× to 79.4×, with a median of 21.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 202631.4×+7.7
2025Dec 31, 202523.7×+3.6
2024Dec 31, 202420.0×+19.4
2023Dec 29, 20230.6×−18.6
2022Dec 30, 202219.2×−35.5
2021Dec 31, 202154.7×–

More Molecular Partners figures

See a number that looks wrong?